Importantly, PPARα knockout exacerbated alcohol-induced fatty liver and liver injury [9], while PPARα agonist administration improved liver pathologies in mice induced by chronic alcohol exposure [2], suggesting that PPARα inhibition is a key mechanism during the development of ALD. This evidence concerns the gene PPARA and fatty liver disease.